GLP-1 Cost in India (2026): ৰোগী আসলে কিমান দেন
Cost often Indian family GLP-1 deciding factor। city, pharmacy, molecule, innovator vs CDSCO generic semaglutide price vary। guide realistic 2026 expense hidden cost insurer ignore, titration budget, employer benefit limitation doctor plan, CDSCO warned misleading online deal chase নহয়। sustainable therapy honest maths: first month titration dose নহয়, first prescription-এর আগে monthly quote × 24।
Short answer
India GLP-1 RA typically ₹8,000–₹25,000/মাহ out of pocket—molecule, dose, innovator vs CDSCO generic, city। most insurance obesity cover নহয়। RSSDI type 2 diabetes clinical use support, reimbursement limited। lab, consultation, 12–24 month therapy budget। licensed pharmacy quote compare। Kesho cost education only—sell/negotiate নহয়। start-এর আগে monthly quote × 24।
Key takeaways
- •২০২৬ most GLP-1 therapy ₹8,000–₹25,000 monthly out of pocket unless employer plan coverage confirm।
- •CDSCO-approved generic semaglutide licensed pharmacy-তে innovator-এর চেয়ে 20–40% cost reduce।
- •Titration lower dose months maintenance-এর চেয়ে কম—minimum 12–24 month budget, first prescription only নহয়।
- •Hidden cost consultation, lab, dietitian, cold-chain travel, sharps disposal—often quarterly ₹2,000–₹5,000।
- •Prescription ছাড়া steep online discount CDSCO-flagged counterfeit/improper storage red flag।
- •Long-term GLP-1 commit-এর আগে realistic maintenance monthly quote × 24 months।
India-তে GLP-1 therapy expensive কেন?
GLP-1 RA relatively new patent-protected/recently off-patent biologic-class complex manufacturing cold-chain rigorous QC। metformin few hundred monthly vs weekly injectable pen device sterile production research cost insurance not cover consumer pass। India vast majority out of pocket public/private insurer obesity pharmacotherapy rarely reimburse diabetes GLP-1 limited select corporate policy। context realistic expectation: significant monthly commitment years diabetes/long-term weight maintenance। early budget treatment interruption glycaemic rebound weight regain prevent। RSSDI type 2 diabetes clinical value recognise guideline support automatic insurance payment নহয়—gap explicitly plan।
২০২৬ molecule অনুযায়ী typical GLP-1 price range?
Exact price fluctuate 2025–2026 Indian pharmacy survey licensed retailer prescription maintenance dose approximate monthly: semaglutide injection weekly ₹8,000–₹18,000 dose product; oral semaglutide ₹10,000–₹20,000; tirzepatide ₹15,000–₹25,000; liraglutide daily ₹6,000–₹12,000; dulaglutide semaglutide similar band। metro sometimes tier-2 higher online competition narrow gap। final invoice GST correct strength pen number confirm month। CDSCO generic semaglutide range lower end available।
Approximate monthly GLP-1 costs (India, 2026)
| Medicine class | Typical monthly range (INR) | Notes |
|---|---|---|
| Semaglutide injection | ₹8,000 – ₹18,000 | Dose and product dependent |
| Oral semaglutide | ₹10,000 – ₹20,000 | Daily tablet; strict timing |
| Tirzepatide | ₹15,000 – ₹25,000 | Dual GIP/GLP-1 agonist |
| Generic semaglutide | ₹6,000 – ₹14,000 | CDSCO-approved only |
| Liraglutide (daily) | ₹6,000 – ₹12,000 | Older GLP-1 RA option |
First-year GLP-1 budget planner (estimated)
| Expense category | Low estimate (INR/year) | High estimate (INR/year) |
|---|---|---|
| Medication only | ₹72,000 | ₹3,00,000 |
| Doctor consultations (quarterly) | ₹3,200 | ₹10,000 |
| Laboratory tests | ₹2,000 | ₹8,000 |
| Dietitian / support care | ₹2,000 | ₹12,000 |
| Travel, storage, supplies | ₹1,000 | ₹5,000 |
| Total first-year range | ₹80,200 | ₹3,35,000 |
Generic semaglutide India cost কেনেকৈ change?
Patent expiry Indian manufacturer CDSCO-approved generic launch lower price sometimes 20–40% below innovator। generic same bioequivalence quality branded। generic consider CDSCO Central Licensing Authority portal approval manufacturer reputation storage verify। unverified online extremely low price counterfeit/improper storage red flag। diabetologist generic name prescription pharmacists local regulation substitute consent। savings multi-year therapy compromised quality clinical benefit safety negate negates। ICMR RSSDI innovator vs generic prefer না both CDSCO-approved same molecule। itemised receipt product name strength month-over-month compare।
City আৰু purchase channel-এ GLP-1 price differ?
Yes modestly। Mumbai Delhi premium ₹500–₹2,000/month tier-2 same CDSCO product। hospital OPD pharmacy standalone sometimes more cold-chain confidence। online licensed promotion injectable temperature-controlled delivery packaging confirm arrival। Hyderabad Chennai Pune corporate hospital generic semaglutide stock competition improve। rural cold-chain-capable pharmacy travel cost। unlicensed messaging-app 50–70% discount never—CDSCO advisory target channels।
GLP-1 therapy vs other obesity interventions (cost view)
| Intervention | Typical upfront cost | Ongoing monthly cost | Notes |
|---|---|---|---|
| GLP-1 pharmacotherapy | Low (first prescription) | ₹8,000–₹25,000 | Schedule H; CDSCO-approved only |
| Structured lifestyle programme | ₹2,000–₹15,000 | ₹500–₹3,000 | ICMR first-line for obesity |
| Bariatric surgery | ₹2,50,000–₹5,00,000+ | Supplements, follow-up | One-time surgical cost |
| Metformin (off-label weight) | Low | ₹100–₹500 | Not primary obesity drug; diabetes use |
Medically reviewed
Dr. Ananya Mehta, MD, DM Endocrinology
Consultant Endocrinologist, India
This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.
Last medically reviewed: Jun 26, 2026